Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies

This article explores the circumstances under which providers and patients should be able to attempt drugs or combinations for indications for which we still lack formal clinical trials.

Detalles Bibliográficos
Autores principales: Mailankody, Sham, Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016075/
https://www.ncbi.nlm.nih.gov/pubmed/27401893
http://dx.doi.org/10.1634/theoncologist.2016-0086
_version_ 1782452537252642816
author Mailankody, Sham
Prasad, Vinay
author_facet Mailankody, Sham
Prasad, Vinay
author_sort Mailankody, Sham
collection PubMed
description This article explores the circumstances under which providers and patients should be able to attempt drugs or combinations for indications for which we still lack formal clinical trials.
format Online
Article
Text
id pubmed-5016075
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AlphaMed Press
record_format MEDLINE/PubMed
spelling pubmed-50160752016-09-14 Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies Mailankody, Sham Prasad, Vinay Oncologist Commentary This article explores the circumstances under which providers and patients should be able to attempt drugs or combinations for indications for which we still lack formal clinical trials. AlphaMed Press 2016-09 2016-07-08 /pmc/articles/PMC5016075/ /pubmed/27401893 http://dx.doi.org/10.1634/theoncologist.2016-0086 Text en ©AlphaMed Press
spellingShingle Commentary
Mailankody, Sham
Prasad, Vinay
Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies
title Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies
title_full Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies
title_fullStr Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies
title_full_unstemmed Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies
title_short Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies
title_sort thinking systematically about the off-label use of cancer drugs and combinations for patients who have exhausted proven therapies
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016075/
https://www.ncbi.nlm.nih.gov/pubmed/27401893
http://dx.doi.org/10.1634/theoncologist.2016-0086
work_keys_str_mv AT mailankodysham thinkingsystematicallyabouttheofflabeluseofcancerdrugsandcombinationsforpatientswhohaveexhaustedproventherapies
AT prasadvinay thinkingsystematicallyabouttheofflabeluseofcancerdrugsandcombinationsforpatientswhohaveexhaustedproventherapies

Ejemplares similares